Assoc. Prof. of Pathology (Clinical) at the University of Utah and Medical Director of Immunology, ARUP Laboratories
BIOGRAPHY
Event Date & Time
Date: May 7, 2024
Time: 8:00 AM (PDT), 11:00 AM (EDT), 5:00 PM (CEST)
Abstract
Antibodies against ribonucleoprotein (RNP) are an important serologic marker for mixed connective tissue disease (MCTD). RNP interacts with Smith (Sm) proteins to form the Sm/RNP complex. Antigens for detecting U1-RNP antibody may include purified extracts (Sm/RNP complex), recombinant proteins, synthetic peptides, or dominant epitopes of the three main proteins (RNPA, RNPC, and RNP68/RNP70) either independently or in various combinations.
Patients with systemic lupus erythematosus frequently have antibodies to both Sm and RNP, whereas patients with MCTD only have antibodies to RNP. RNP antibodies can be detected using diverse types of solid-phase immunoassays. As a consequence of the variety of antigens and methods in use, considerable confusion exists regarding nomenclature, reporting and interpretation of anti-RNP testing.
In this webinar, we will review the various RNP antigens and methods for antibody detection, and use case studies to illustrate challenges associated with interpretation of results and approaches for improving the nomenclature for reporting RNP antibodies.
Learning Objectives
- Describe the role of RNP antibodies in the diagnosis of mixed connective tissue disease (MCTD)
- Discuss the variety of antigens and methods used to detect RNP antibodies
- Recognize differences in how RNP antibody results are reported that may lead to confusion
Webinars will be available for unlimited on-demand viewinga fter live event.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...